logo
With rising temperatures in North Carolina, hospitals report uptick of snake bites

With rising temperatures in North Carolina, hospitals report uptick of snake bites

Yahoo20-06-2025

CARY, N.C. (WNCN) — Hospitals throughout the central North Carolina said they're seeing more patients with snake bites walking through their doors.
Raleigh native Anita McLoud went through the whole experience when she was bitten by a copperhead in her backyard. She never imagined she'd find herself calling 911 in the hospital, and with a venomous bite.
After checking on her chickens during a night in August, McLoud said she turned around to walk back to her house when she had a startling surprise.
'One of the first two things I remember learning from my mom is how to identify a copperhead and how to identify poison ivy,' McLoud said. 'Those were the things you needed to know going out of the house.
'I was in my backyard,' she said. 'I had not seen a snake there in 23 years that I lived there and I was wearing flip flops.'
'My first thought was it's a stick. Within a split second, I [realized] that was not a stick. Was it a snake? I turned and there he was.'
According to McLoud, medical staff measured the swelling near the bite every 30 minutes. While she never needed antivenom, doctors gave her morphine for the pain. She said the swelling, pain, and discoloration lasted around five-six weeks.
'I was fortunate that way,' McLoud said. 'They told me at the time, only 23% of people who got bit had to receive the antivenom.'
According to Duke Health officials, hospitals usually see more than 100 snakebite patients per year across the health system, with the number of cases typically peaking in July.
Since April, officials said emergency departments at Duke University, Duke Regional Hospital and Raleigh Regional Hospital have treated 22 bites this season, which staff said typically starts in April.
Officials at WakeMed said an emergency department reported nine patients since June 1, six just between June 14 and June 17. Last year, they saw an increase from 15 patients treated for bites in June to 40 in July.
UNC Hospitals in Chapel Hill reported 18 patients from March to mid-June, slightly higher than the same time last year.
'The numbers increase as the weather gets warmer, especially when it's hot and more of us work/play in the yard early in the morning or in the evening—when snakes get more active, too,' staff said in a statement.
Talena Chavis of Cary, the owner of NC Snake Catcher has studied snakes for nearly 30 years. She said the summer season typically comes with 8-10 calls a day, often to safely move and relocate snakes.
'I actually don't encourage folks to try to ID snakes themselves because Mother Nature throws curveballs,' Chavis said. 'Even with copperheads, the pattern changes a lot.'
North Carolina has six venomous snakes. According to Chavis, the copperhead's bite is rarely fatal.
'Every season, copperheads are our number one snake,' Chavis said. 'To say that we have a surplus or even an overpopulation is not is not off topic.'
Chavis believes more encounters have been attributed to more growth and development. The species has also adapted to urban and suburban areas.
'They're not really afraid of loud noises,' she said. 'They don't care about fireworks, blowers, lawnmowers. These guys just don't really care because they're an ambush predator.'
According to Chavis, most bites happen during night hours when copperheads are searching for heat and their prey. Most the time, she said people just happen to get in the way.
Chavis advises people to be more cautious, aware, and put on boots.
'I firmly believe if people wore their boots in the yard and watched where they put their hands, the number of copperhead bites would be cut in half,' she said.
Even after her encounter, McLoud said she now works with the reptiles.
'I've really been enjoying it,' McLoud said. 'I wasn't upset with the snake. He's just doing his 'self-defense' thing. If someone stepped on me, I'd probably react as well.'
Duke Health officials also continue to share more information about snakebite safety. If bitten, they said to go to your local hospital—never push off the visit.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition

Yahoo

time38 minutes ago

  • Yahoo

Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 26, William Blair reaffirmed its 'Market Perform' rating for Maravai stock. The key factor influencing this move is the leadership changes at Maravai. A scientist performing a blood test on a patient using life sciences tools & services. Maravai has undergone a complete leadership overhaul since December last year. In December 2024, the company brought in Andy Eckert as the new independent Chairman of the Board. Later, Maravai installed Bernd Brust as CEO, replacing Trey Martin. Then, on June 25, a new press release indicated that Rajesh 'Raj' Asarpota would assume the position of Executive Vice President and Chief Financial Officer, effective June 30. According to William Blair, Brust and Asarpota are joining Maravai's top-level management when the company is undergoing 'a challenging operational transition period.' The analysts noted that the company 'faces approximately $66 million in headwinds in 2025 from declining COVID-related revenues.' As such, the analysts are optimistic that the fresh hands at Maravai's helm will inject more momentum into the transition. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a life sciences company. It provides specialized products that support the development of vaccines, drug therapies, diagnostics, and cell and gene therapies. Its operations span two segments: Nucleic Acid Production and Biologics Safety Testing. While we acknowledge the potential of MRVI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Ardelyx (ARDX) Appoints New Chief Business and HR Officers
Ardelyx (ARDX) Appoints New Chief Business and HR Officers

Yahoo

time38 minutes ago

  • Yahoo

Ardelyx (ARDX) Appoints New Chief Business and HR Officers

Ardelyx, Inc. (NASDAQ:ARDX) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 2, the company announced two key appointments to its leadership team. Mike Kelliher, who joined the company in March 2024, was promoted from his previous role as Executive Vice President, Corporate Development and Strategy to Chief Business Officer (CBO). James P. Brady joined Ardelyx as the new Chief Human Resources Officer (CHRO). Both Kelliher and Brady report directly to Mike Raab, the company's President and CEO. A pharmacy worker distributing prescription medicines to patientsreceiving treatment for oncology, cardiovascular, renal, metabolism and respiratory diseases. Ardelyx said that these appointments are part of its strategy to strengthen its leadership team. The move, the company stated, is crucial to advancing its commercial and clinical programs. 'As we continue to grow and evolve our business, it is imperative that we have high caliber leaders, like Mike and Jamie, who will enable us to accelerate our momentum and deliver long-term impact for patients and shareholders,' said Raab. The CEO highlighted Kelliher's experiences, business intuition, and leadership as bringing 'incredible value' to Ardelyx. On the other hand, he expressed excitement about welcoming Brady, emphasizing his talent as an HR executive and his extensive experience in people development, which will be influential in advancing key business initiatives and talent strategies. Ardelyx, Inc. (NASDAQ:ARDX) is a biopharmaceutical company. It discovers, develops, and commercializes first-in-class medicines for gastrointestinal and kidney diseases. Its key products include IBSRELA (for irritable bowel syndrome with constipation) and XPHOZAH (a phosphate absorption inhibitor for chronic kidney disease patients on dialysis). Ardelyx serves adult patients in the United States and internationally. While we acknowledge the potential of ARDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nightclub worker diagnosed with brain tumour reveals key early sign
Nightclub worker diagnosed with brain tumour reveals key early sign

Yahoo

timean hour ago

  • Yahoo

Nightclub worker diagnosed with brain tumour reveals key early sign

A Birmingham nightclub worker was diagnosed with a brain tumour after getting lost in a place he knew "like the back of his hand". Tom Weatherstone, from Sheldon, had visited Perranporth in Cornwall all his life but couldn't find his way back from the beach in summer 2022. After he was diagnosed, he said his confusion may have been the first sign something was wrong. READ MORE: Dad who built £180k back garden bungalow for ill father has days to tear it down He also started having headaches, sickness and blurry pixelated vision in his right eye but his family believed they were linked to his job and lifestyle. He was diagnosed less than a year later after he was sent for blood tests and a CT scan by a doctor who spotted his hand tremors during a routine and unrelated private appointment in March 2023. The now-23-year-old was previously told he had a vitamin deficiency following a telephone consultation with his GP and was prescribed vitamin B12, D and folic acid. He was told he needed surgery to treat it, which could result in him losing his sight, his memory, his mobility or even his speech. Tom said: 'Retrospectively, the first sign came earlier, during a family holiday in the summer of 2022. 'One day, I walked back from the beach and got lost in a place I had known my whole life like the back of my hand. "At the time, it seemed odd, but we didn't think much of it. Looking back, it was the beginning of something none of us could have imagined.' READ MORE: City station attacker who 'bit and clawed' police dies at bail hostel Tom's oldest sister, Josie, 27, said: 'When Tom started having headaches, throwing up, vision problems, and noticing a tremor in his hand, we put it down to his lifestyle and assumed his job in a nightclub, the noise and bright lights were the cause. 'After Tom was diagnosed with a mineral deficiency, none of us thought it was a symptom of a brain tumour.' Tom continued: 'I had more bloods taken, another CT scan, and a sight test done at Heartlands Hospital in March 2023. 'By early the next morning, they confirmed again there was something there. 'I was transferred that same day to the Queen Elizabeth Hospital in Birmingham. I remember the anxiety building. 'I was scared. I just wanted to know what was in my head that was causing so much alarm.' At the QE, Tom was diagnosed with an astrocytoma, a tumour which develops from star-shaped glial cells, and had urgent surgery to fit a shunt to relieve pressure on his brain and a biopsy. He said: 'Doctors said the risks of surgery were loss of sight, mobility, memory or even speech loss. 'I was on my own, no family, and the doctor just said: 'It's a tumour'. I didn't know what to say. 'I rang my family straight away, I was in shock, devastated. 'I'd gone to the doctor for a routine check and now I was in hospital with a brain tumour.' Tom had a second operation on May 22 2023 to 'debulk' the tumour, which resulted in the partial loss of peripheral vision in his right eye. READ MORE: Hero police officer saves woman from dog attack which nearly killed her Five days later, Tom returned home to recover, but at his follow-up appointment, he was given the devastating news that the tumour had progressed from grade 2 to grade 4. He said: 'When I heard it was grade 4, I put on a brave face, but inside I was crushed. 'I stayed positive, I had to, but it wasn't easy.' Tom underwent six weeks of radiotherapy, followed by a year of chemotherapy. In December 2024, an MRI scan revealed a second astrocytoma, inoperable due to its sensitive location, but stable. A third tumour is not responding to treatment. He now undergoes MRI scans every three months. Now Josie and Tom's younger sister Gemma, 19, are taking on the 88 Squats a Day in July challenge to raise money for Brain Tumour Research in support of Tom and others affected. They can be backed on their JustGiving page here. Josie said: 'If we'd known Tom's symptoms were those of a brain tumour, we'd have taken him straight to hospital. 'I'm taking on the 88 Squats a Day Challenge for Tom because no-one should have to go through what he has. 'Watching someone you love face a brain tumour is heartbreaking. 'If raising awareness and money helps even one family get an earlier diagnosis or better treatment, every squat is worth it.' Get the latest BirminghamLive news direct to your inbox Katrina Jones, head of community and digital fundraising at Brain Tumour Research, said: 'We're incredibly grateful to Josie for taking on the 88 Squats Challenge in support of Tom. 'Her determination and strength are truly inspiring. 'Brain tumours are the biggest cancer killer of children and adults under 40 in the UK, yet research into them remains severely underfunded. 'Supporters like Josie play a vital role in helping us fund the research needed to improve outcomes and ultimately find a cure." Brain Tumour Research funds sustainable research at dedicated centres in the UK. It also campaigns for the Government and larger cancer charities to invest more in research into brain tumours to speed up new treatments for patients and, ultimately, find a cure. The charity is the driving force behind the call for a national annual spend of £35 million to improve survival rates and patient outcomes in line with other cancers such as breast cancer and leukaemia.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store